NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,739,735 | -30.5% | 506,750 | -8.1% | 0.03% | -25.7% |
| Q2 2023 | $14,015,698 | -20.3% | 551,365 | +13.3% | 0.04% | -30.0% |
| Q1 2023 | $17,591,205 | +9.3% | 486,617 | +19.7% | 0.05% | -2.0% |
| Q4 2022 | $16,096,766 | +0.2% | 406,484 | +18.0% | 0.05% | -7.3% |
| Q3 2022 | $16,057,000 | +6.4% | 344,577 | +0.0% | 0.06% | +10.0% |
| Q2 2022 | $15,098,000 | -47.2% | 344,472 | -12.9% | 0.05% | -40.5% |
| Q1 2022 | $28,590,000 | -18.7% | 395,277 | -8.9% | 0.08% | +12.0% |
| Q4 2021 | $35,182,000 | +4098.3% | 433,968 | +5927.3% | 0.08% | +3650.0% |
| Q3 2021 | $838,000 | +29.5% | 7,200 | +84.6% | 0.00% | +100.0% |
| Q2 2021 | $647,000 | -86.5% | 3,900 | -88.7% | 0.00% | -92.3% |
| Q1 2021 | $4,810,000 | +98.5% | 34,480 | +146.3% | 0.01% | +85.7% |
| Q4 2020 | $2,423,000 | -52.7% | 13,997 | -61.9% | 0.01% | -61.1% |
| Q3 2020 | $5,122,000 | -50.1% | 36,773 | -57.2% | 0.02% | -64.7% |
| Q2 2020 | $10,256,000 | -14.2% | 85,846 | -28.2% | 0.05% | -47.4% |
| Q1 2020 | $11,958,000 | -63.1% | 119,607 | -56.7% | 0.10% | -1.0% |
| Q4 2019 | $32,444,000 | +312.2% | 276,028 | +201.5% | 0.10% | +276.9% |
| Q3 2019 | $7,870,000 | +474.0% | 91,549 | +333.1% | 0.03% | +550.0% |
| Q2 2019 | $1,371,000 | -75.0% | 21,137 | -75.9% | 0.00% | -77.8% |
| Q1 2019 | $5,488,000 | +1785.9% | 87,791 | +1074.6% | 0.02% | +1700.0% |
| Q4 2018 | $291,000 | +27.6% | 7,474 | +86.8% | 0.00% | 0.0% |
| Q3 2018 | $228,000 | -58.6% | 4,000 | -42.0% | 0.00% | -50.0% |
| Q2 2018 | $551,000 | -65.4% | 6,900 | -62.5% | 0.00% | -60.0% |
| Q1 2018 | $1,594,000 | +261.5% | 18,400 | +181.9% | 0.01% | +150.0% |
| Q4 2015 | $441,000 | -80.2% | 6,526 | -84.2% | 0.00% | -80.0% |
| Q2 2015 | $2,226,000 | – | 41,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |